Lifeboat Foundation

Summary: It may be possible to optimize the stimulation parameters of brain implants in animals without human intervention. The study highlights the potential for autonomous optimization of prostheses implanted in the brain. The advance may prove to be beneficial for those with spinal cord injury and diseases that affect movement.

Source: University of Montreal.

Scientists have long studied neurostimulation to treat paralysis and sensory deficits caused by strokes and spinal cord injuries, which in Canada affect some 380,000 people across the country.

A causal relationship exists among the aging process, organ decay and dis-function, and the occurrence of various diseases including cancer. A genetically engineered mouse model, termed Eklf^K74R/K74R or Eklf (K74R), carrying mutation on the well-conserved sumoylation site of the hematopoietic transcription factor KLF1/ EKLF has been generated that possesses extended lifespan and healthy characteristics including cancer resistance. We show that the high anti-cancer capability of the Eklf (K74R) mice are gender-, age-and genetic background-independent. Significantly, the anti-cancer capability and extended lifespan characteristics of Eklf (K74R) mice could be transferred to wild-type mice via transplantation of their bone marrow mononuclear cells. Targeted/global gene expression profiling analysis has identified changes of the expression of specific proteins and cellular pathways in the leukocytes of the Eklf (K74R) that are in the directions of anti-cancer and/or anti-aging. This study demonstrates the feasibility of developing a novel hematopoietic/ blood system for long-term anti-cancer and, potentially, for anti-aging.

The authors have declared no competing interest.

Aging clocks estimate how fast specific organs are deteriorating—but it’s hard to know what to do with the results.

What if we could just skip the workout part and take the results in supplement form? Researchers did it… On mice and flies.

EXPERTS:

It’s a step that could one day lead to advances for humans that boost quality of life for many by: giving amputees and those with spinal injuries control of advanced prosthetics, stimulating the sacral nerve to restore bladder control, stimulating the cervical vagus nerve to treat epilepsy and providing deep brain stimulation as a possible treatment for Parkinson’s.

How far would you go to keep your mind from failing? Would you go so far as to let a doctor drill a hole in your skull and stick a microchip in your brain?

It’s not an idle question. In recent years neuroscientists have made major advances in cracking the code of memory, figuring out exactly how the human brain stores information and learning to reverse-engineer the process. Now they’ve reached the stage where they’re starting to put all of that theory into practice.

Last month two research teams reported success at using electrical signals, carried into the brain via implanted wires, to boost memory in small groups of test patients. “It’s a major milestone in demonstrating the ability to restore memory function in humans,” says Dr. Robert Hampson, a neuroscientist at Wake Forest School of Medicine and the leader of one of the teams.

Researchers show how Stable Diffusion can read minds. The method reconstructs images from fMRI scans with amazing accuracy.

Researchers have been using AI models to decode information from the human brain for years. At their core, most methods involve using pre-recorded fMRI images as input to a generative AI model for text or images.

In early 2018, for example, a group of researchers from Japan demonstrated how a neural network reconstructed images from fMRI recordings. In 2019, a group reconstructed images from monkey neurons, and Meta’s research group, led by Jean-Remi King, has published new work that derives text from fMRI data, for example.

Neuralace™ is a glimpse of what’s possible in the future of BCI.

This patent pending concept technology is the start of Blackrock’s journey toward whole-brain data capture–with transformative potential for the way neurological disorders are treated. With over 10,000 channels and a flexible lace structure that seamlessly conforms to the brain, Neuralace has potential applications in vision and memory restoration, performance prediction, and the treatment of mental health disorders like depression.

Continue reading “Neuralace™ | The next-generation of BCI and whole-brain data capture” »

Blackrock’s long-tested NeuroPort® Array, widely considered the gold standard of high-channel neural interfacing, has been used in human BCIs since 2004 and powered many of the field’s most significant milestones. In clinical trials, patients using Blackrock’s BCI have regained tactile function, movement of their own limbs and prosthetics, and the ability to control digital devices, despite diagnoses of paralysis and other neurological disorders.

While Blackrock’s BCI enables patients to execute sophisticated functions without reliance on assistive technologies, next-generation BCIs for areas such as vision and memory restoration, performance prediction, and treatment of mental health disorders like depression will need to interface with more neurons.

Neuralace is designed to capitalize on this need; with 10,000+ channels and the entire scalable system integrated on an extremely flexible lace-structured chip, it could capture data that is orders of magnitude greater than existing electrodes, allowing for an exponential increase in capability and intuitiveness.